Sustained release vaccine platforms for enhanced humoral immunity

Conference Dates

June 5-9, 2018


Vaccines aim to modulate the immune system to elicit a sufficiently robust, yet targeted, immune response with specifiable immune cell phenotypes.1,2 Failure of a single vaccine administration to elicit such a response likely arises from inappropriate temporal control over antigen/adjuvant presentation and immune cell activation.2 Recent work demonstrates the potential for sustained, low-level presentation of antigens and adjuvants for just over a week to yield more potent and long-lasting immunity.3

Please download the file below for full content.

47.pdf (318 kB)

This document is currently not available here.